Nucleic Acid Solutions 4basebio specializes in designing, manufacturing, and supplying synthetic DNA and mRNA constructs along with non-viral delivery systems, presenting strong cross-sell opportunities to biotech firms needing customized nucleic acid materials and delivery vectors for gene therapies and vaccines.

Hermes Delivery Their proprietary Hermes non-viral delivery system offers targeted nanoparticle delivery, which could be pitched to companies seeking safer, scalable alternatives to viral vectors or non-targeted LNPs for cell and gene therapies.

Clinical & Vaccine Ready With capabilities spanning genome editing, vaccines, and therapeutics using DNA constructs and delivery platforms, 4basebio is positioned to collaborate with biotechs progressing clinical programs that require rapid-turnaround, customizable DNA tools.

Growth & Partnerships Funding of around $90M and revenue in the low millions indicate a scalable growth phase; target strategic partnerships or co-development deals with mid-size biotechs and contract research organizations seeking specialized nucleic acid solutions.

Tech & Compliance Adoption of modern tech stack and credentials (HubSpot, cloud CDN, NEBOSH) signals readiness for regulated, customer-centric operations; use this to position robust compliance, quality, and lifecycle support in sales discussions with risk-aware buyers.